The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a phase III trial.
New treatment option for endometrial cancer shows promise in phase II trial
- Post author:
- Post published:
- Post category:uncategorized